Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869210/
https://www.ncbi.nlm.nih.gov/pubmed/29595841
http://dx.doi.org/10.1136/rmdopen-2017-000582corr1
_version_ 1783309240717279232
collection PubMed
description
format Online
Article
Text
id pubmed-5869210
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58692102018-03-28 Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis RMD Open Correction BMJ Publishing Group 2018-03-26 /pmc/articles/PMC5869210/ /pubmed/29595841 http://dx.doi.org/10.1136/rmdopen-2017-000582corr1 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Correction
Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title_full Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title_fullStr Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title_full_unstemmed Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title_short Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
title_sort correction: 4-year results from the rapid-psa phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869210/
https://www.ncbi.nlm.nih.gov/pubmed/29595841
http://dx.doi.org/10.1136/rmdopen-2017-000582corr1

Ejemplares similares